NANOSPHERE HEA.SCIENCES Market Cap ($96.10K)
Market Cap & Net Worth: NANOSPHERE HEA.SCIENCES (2CG)
NANOSPHERE HEA.SCIENCES market cap. NANOSPHERE HEA.SCIENCES (F:2CG) has a market capitalization of $96.10K (€82.20K) as of November 3, 2026. Listed on the F stock exchange, this Germany-based company holds position #31546 globally and #2813 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NANOSPHERE HEA.SCIENCES's stock price €0.01 by its total outstanding shares 10275205 (10.28 Million).
NANOSPHERE HEA.SCIENCES Market Cap History (2017–2026)
NANOSPHERE HEA.SCIENCES market cap history from 2017 to 2026. Data shows change from $98.99 Million to $96.10K (-54.71% CAGR). Check NANOSPHERE HEA.SCIENCES stock quote for real-time trading data and today's change.
NANOSPHERE HEA.SCIENCES Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NANOSPHERE HEA.SCIENCES's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 2CG by Market Capitalization
Companies near NANOSPHERE HEA.SCIENCES in the global market cap rankings as of November 3, 2026.
Key companies related to NANOSPHERE HEA.SCIENCES by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #372 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #411 globally with a market cap of $69.05 Billion USD ( AU$97.59 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #497 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $553.15 |
| #372 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $961.26 |
| #411 | CSL Ltd | AU:CSL | $69.05 Billion | AU$201.16 |
| #497 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $220.83 |
Market Capitalization of NANOSPHERE HEA.SCIENCES (2017–2026)
Market capitalization of NANOSPHERE HEA.SCIENCES from 2017 to today. Between 2017 and today, NANOSPHERE HEA.SCIENCES's market cap moved from $98.99 Million to $ 96.10K, with a yearly change of -54.71%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €96.10K | +1500.00% |
| 2025 | €6.01K | -95.00% |
| 2024 | €120.13K | +400.00% |
| 2023 | €24.03K | -82.61% |
| 2022 | €138.15K | -89.82% |
| 2021 | €1.36 Million | -5.83% |
| 2020 | €1.44 Million | -79.59% |
| 2019 | €7.06 Million | -76.29% |
| 2018 | €29.79 Million | -69.90% |
| 2017 | €98.99 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of NANOSPHERE HEA.SCIENCES was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $96.10K USD |
| MoneyControl | $96.10K USD |
| MarketWatch | $96.10K USD |
| marketcap.company | $96.10K USD |
| Reuters | $96.10K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About NANOSPHERE HEA.SCIENCES
NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Delivery System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, animal health, and other industries. NanoSphere Health Sciences … Read more